Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — most people do regain some weight after stopping Mounjaro. Clinical trials show that the appetite-suppressing effects of tirzepatide reverse when treatment ends, and body weight typically begins to rise within weeks. How much comes back, and how quickly, depends on factors your prescriber can help you think through. Mounjaro (tirzepatide) is a prescription-only medicine; whether stopping, continuing or transitioning to another approach is right for you is a clinical decision, not one to make alone. Our clinical team reviews exactly these situations every day.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, that together reduce appetite, slow gastric emptying and help regulate fat storage. While the medicine is present, those signals are amplified far beyond baseline. When you stop, they drop back. Hunger returns, often quite quickly. Food feels less filling than it did on treatment. The body's own attempts to defend a higher set-point weight (a well-documented biological drive, not a character flaw) reassert themselves.
This is why weight gain after stopping Mounjaro follows a predictable pattern rather than being random. It is the same biological mechanism that makes long-term management of obesity inherently difficult for most people. Understanding that helps remove the self-blame that often comes with regain. You can read more about the biological basis of weight management on the tirzepatide overview page.
The appetite suppression fades within days to a few weeks of the last dose. Gastric-emptying speed gradually normalises too. Body weight typically begins to climb within the first month of stopping, then continues to rise for several months before a new plateau is reached, usually, though not always, at a weight higher than the lowest point reached on treatment.
The SURMOUNT-4 trial is the most relevant published data here. Participants who had lost weight on tirzepatide and then switched to placebo regained approximately two-thirds of their lost weight over the following year. Those who continued on tirzepatide maintained their loss. The data are consistent with what was seen in semaglutide extension studies, published in the STEP 1 trial programme, where regain after stopping semaglutide followed a similar trajectory.
That two-thirds figure is not universal. People who made the most durable changes to eating patterns and activity during treatment tended to regain less. Age, starting weight, how long treatment lasted and the presence of underlying metabolic conditions all influence the picture. If you want to understand more about how this medicine works before drawing conclusions, our page explaining what Mounjaro means and how it is classified gives useful context. But the broad direction is consistent: stopping treatment without sustained support leads to meaningful weight gain after stopping Mounjaro for the majority of people.
This does not mean treatment must continue indefinitely, or that stopping is the wrong decision for everyone. It means the decision deserves proper clinical thought. If cost is part of what you are weighing up, our Mounjaro cost page explains what a private prescription actually includes so you can compare fairly.
There is no reliably simple answer to how to not gain weight after stopping Mounjaro, and content that promises one is overstating what the evidence supports. What is well-evidenced is a set of behaviours that blunt, though rarely eliminate, regain.
Adequate protein intake is consistently associated with better weight maintenance, partly because it preserves muscle during any energy deficit and partly because it supports satiety independent of medication. Strength-based exercise helps too, both for metabolic rate and for preserving lean mass. Processed, calorie-dense foods that were easier to resist on treatment become harder to moderate once appetite is no longer pharmacologically supported, so reducing their availability in your home environment often matters more than willpower.
Sleep, stress and social factors all shape weight after treatment ends. The NHS England guidance on weight management injections emphasises that behavioural support alongside medication improves outcomes, the same principle applies when medication ends. These changes are not quick fixes, but they are cumulative. A dietitian or health coach can help structure them practically. Our weight-loss treatment overview covers the broader support picture.
Returning to Mounjaro after stopping is clinically possible if you remain eligible, the page on restarting Mounjaro covers this in detail. Eligibility is re-assessed at the point of any new prescription; a prescriber will look at your current weight, any changes in health conditions and your reasons for stopping previously.
For people who stopped because of side effects, a different dose or a different medicine may be worth discussing. For people who stopped because of cost or logistics, circumstances change, and a fresh consultation gives you current options. At nume, every repeat prescription (and every new start) is reviewed by a prescriber rather than processed automatically. There is no subscription that keeps sending pens without anyone checking. If you want to explore where you stand now, starting a free consultation is the practical next step. The process is straightforward: your answers go to a prescriber the same day, and if treatment is clinically suitable you will know quickly.
The broader picture of whether you put weight back on after stopping Mounjaro is covered on our dedicated page about what to expect after stopping Mounjaro, including what to expect with energy levels, appetite and any side effects that were present during treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.